Maa Ambika Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Maa Ambika Pharma
Maa Ambika Pharma Private Limited (MAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2022 (Two years and seven months 11 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nenmal Jain, Srijith Neelnath, and Raman Kumaran serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52202KA2022PTC163107
-
Company No.
163107
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jun 2022
-
Date of AGM
31 Oct 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Maa Ambika Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nenmal Jain
|
Director | 29-Jun-2022 | Current |
|
Srijith Neelnath
|
Director | 29-Jun-2022 | Current |
|
Raman Kumaran
|
Director | 29-Jun-2022 | Current |
Financial Performance of Maa Ambika Pharma.
Enhance accessibility to Maa Ambika Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maa Ambika Pharma?
Unlock access to Maa Ambika Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Suncure Pharmaceutical Private LimitedNenmal Jain is a mutual person
-
Frontiernext Solutions Private Limited
Srijith Neelnath is a mutual person
-
Amrita Pharma Private Limited
Raman Kumaran is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maa Ambika Pharma?
Maa Ambika Pharma has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maa Ambika Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maa Ambika Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
